Complications of Midline Catheter in Surgical Children (MIDline)

April 14, 2026 updated by: Hee-Soo Kim, Seoul National University Hospital

Study on Complications After Midline Catheter Placement and the Risk Factors in Children

The goal of this observational study is to understand the incidence and risk factors of complications associated with midline catheter placement in pediatric patients (under 18 years old) undergoing general anesthesia. The main questions it aims to answer are:

What is the overall complication rate (including malfunction, bleeding, thrombosis, inflammation, and infection) after midline catheter placement in children?

What factors (e.g., age, weight, vein diameter, insertion site, catheter maintenance duration) are associated with a higher risk of complications?

Participants will:

Receive a midline catheter during surgery under general anesthesia.

Undergo ultrasound-guided assessment of the catheter site immediately after placement, 24 hours later, and before the catheter is removed.

Be monitored for any complications related to the catheter, including infection, blood clots, or blockage.

This study will help identify which factors increase the risk of complications, improving the safe use of midline catheters in pediatric patients.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, South Korea, 03080
        • Seoul National University Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

The study will include pediatric patients under 18 years of age who are undergoing general anesthesia for surgery at Seoul National University Hospital and require midline catheter placement. This population is selected to investigate the incidence and risk factors for complications associated with midline catheter insertion in pediatric patients.

Description

Inclusion Criteria:

  • Pediatric patients under 18 years of age
  • Scheduled to undergo general anesthesia for surgery at Seoul National University Children's Hospital.
  • Clinically indicated for midline catheter insertion as determined by the attending anesthesiologist.

Exclusion Criteria:

  • Patients requiring central venous catheter (CVC) insertion instead of a midline catheter.
  • Known coagulation disorders.
  • History of severe thrombosis.
  • Any other conditions that, in the investigator's judgment, make the patient unsuitable for the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
midline catheter inserted group
This intervention involves the ultrasound-guided insertion of a midline catheter into a peripheral vein (basilic, cephalic, or brachial vein) during general anesthesia in pediatric patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Complications Related to Midline Catheter
Time Frame: From midline catheter insertion to catheter removal (up to 7 days).
The overall complication rate is defined as the proportion of patients experiencing any catheter-related complications, including catheter malfunction, infection (clinical signs or positive culture), bleeding at the insertion site, thrombosis (confirmed by ultrasound), and catheter dislodgement.
From midline catheter insertion to catheter removal (up to 7 days).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Each Type of Complication
Time Frame: From midline catheter insertion to catheter removal (up to 7 days).

The incidence of each specific complication type will be recorded, including:

Catheter malfunction (clinical assessment), Infection (clinical signs or positive culture), Bleeding at the insertion site (visual inspection), Thrombosis (confirmed by ultrasound), Catheter dislodgement (clinical assessment)

From midline catheter insertion to catheter removal (up to 7 days).
Midline Catheter Maintenance Duration
Time Frame: From midline catheter insertion to catheter removal (up to 7 days).
The total duration (in days) that each patient maintains a functional midline catheter without premature removal.
From midline catheter insertion to catheter removal (up to 7 days).
Number of Participants with Premature Catheter Removal and Reasons
Time Frame: From midline catheter insertion to catheter removal (up to 7 days).
The primary reason for catheter removal will be documented, including: Planned removal (completion of clinical need), Premature removal due to complications (infection, malfunction, thrombosis, or patient discomfort)
From midline catheter insertion to catheter removal (up to 7 days).
Number of Participants with Thrombosis Confirmed by Ultrasound
Time Frame: From midline catheter insertion to catheter removal (up to 7 days)
The presence of thrombosis at the catheter site will be assessed using ultrasound. Ultrasound will be performed immediately after insertion, 24 hours later, and at the time of catheter removal. Thrombosis will be defined as the presence of an intraluminal thrombus or significant vein narrowing.
From midline catheter insertion to catheter removal (up to 7 days)
Number of participants receiving treatment for Complications
Time Frame: From midline catheter insertion to catheter removal (up to 7 days)

This outcome measures the frequency and types of treatments administered for complications associated with the midline catheter, including:

  • Antibiotics for infection (based on clinical signs or positive culture).
  • Anticoagulants for thrombosis (confirmed by ultrasound).
  • Additional catheter procedures (replacement, adjustment, or removal).
  • Analgesics or anti-inflammatory medications for local inflammation or pain. Each treatment will be documented, including the type, dose, route, and reason for administration.
From midline catheter insertion to catheter removal (up to 7 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2025

Primary Completion (Actual)

December 23, 2025

Study Completion (Actual)

December 30, 2025

Study Registration Dates

First Submitted

May 9, 2025

First Submitted That Met QC Criteria

May 11, 2025

First Posted (Actual)

May 18, 2025

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 14, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2503-174-1626

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Midline Catheter

Clinical Trials on midline catheter insertion during general anesthesia

3
Subscribe